AUPH vs. VSEC
AUPH (Aurinia Pharmaceuticals Inc.) and VSEC (VSE Corporation) are both stocks. AUPH operates in Biotechnology (Healthcare), while VSEC operates in Aerospace & Defense (Industrials). Over the past 10 years, AUPH returned 17.98%/yr vs 19.16%/yr for VSEC. At a 0.17 correlation, their price movements are largely independent.
Performance
AUPH vs. VSEC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AUPH achieves a -1.76% return, which is significantly lower than VSEC's 1.98% return. Over the past 10 years, AUPH has underperformed VSEC with an annualized return of 17.98%, while VSEC has yielded a comparatively higher 19.16% annualized return.
AUPH
- 1D
- 1.82%
- 1M
- -0.63%
- YTD
- -1.76%
- 6M
- 5.10%
- 1Y
- 95.87%
- 3Y*
- 17.99%
- 5Y*
- 4.66%
- 10Y*
- 17.98%
VSEC
- 1D
- -2.31%
- 1M
- 4.71%
- YTD
- 1.98%
- 6M
- 4.52%
- 1Y
- 34.31%
- 3Y*
- 51.83%
- 5Y*
- 29.45%
- 10Y*
- 19.16%
AUPH vs. VSEC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | -1.76% | 77.62% | -0.11% | 108.10% | -81.11% | 65.37% | -31.74% | 197.07% | 50.55% | 115.71% |
VSEC VSE Corporation | 1.98% | 82.26% | 47.93% | 39.19% | -22.35% | 59.55% | 2.54% | 28.56% | -37.81% | 25.45% |
Correlation
The correlation between AUPH and VSEC is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 4, 2014 | 0.17 |
Fundamentals
AUPH:
$2.16B
VSEC:
$4.90B
AUPH:
$2.15
VSEC:
$2.73
AUPH:
7.30
VSEC:
64.50
AUPH:
0.00
VSEC:
0.91
AUPH:
7.30
VSEC:
3.43
AUPH:
3.80
VSEC:
1.84
AUPH:
$298.30M
VSEC:
$1.18B
AUPH:
$267.70M
VSEC:
$105.32M
AUPH:
$153.45M
VSEC:
$128.59M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUPH vs. VSEC — Risk / Return Rank
AUPH
VSEC
AUPH vs. VSEC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and VSE Corporation (VSEC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AUPH | VSEC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.49 | ||
| Sortino ratioReturn per unit of downside risk | +1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.16 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 6.06 | 1.14 | +4.92 |
| Martin ratioReturn relative to average drawdown | 13.22 | 3.29 | +9.93 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| AUPH | VSEC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | 0.64 | +1.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.07 | 0.64 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.41 | -0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.26 | -0.10 |
Drawdowns
AUPH vs. VSEC - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than VSEC's maximum drawdown of -76.09%. Use the drawdown chart below to compare losses from any high point for AUPH and VSEC.
Loading charts...
Drawdown Indicators
| AUPH | VSEC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.58% | -76.09% | -11.49% |
Max Drawdown (1Y)Largest decline over 1 year | -15.91% | -30.31% | +14.40% |
Max Drawdown (3Y)Largest decline over 3 years | -60.80% | -30.31% | -30.49% |
Max Drawdown (5Y)Largest decline over 5 years | -87.58% | -47.58% | -40.00% |
Max Drawdown (10Y)Largest decline over 10 years | -87.58% | -76.09% | -11.49% |
Current DrawdownCurrent decline from peak | -52.63% | -22.68% | -29.95% |
Average DrawdownAverage peak-to-trough decline | -49.22% | -30.68% | -18.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.28% | 10.47% | -3.19% |
Volatility
AUPH vs. VSEC - Volatility Comparison
The current volatility for Aurinia Pharmaceuticals Inc. (AUPH) is 10.84%, while VSE Corporation (VSEC) has a volatility of 22.49%. This indicates that AUPH experiences smaller price fluctuations and is considered to be less risky than VSEC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AUPH | VSEC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.84% | 22.49% | -11.65% |
Volatility (6M)Calculated over the trailing 6-month period | 24.40% | 45.62% | -21.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.17% | 53.79% | -8.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.49% | 46.09% | +21.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.99% | 46.97% | +27.02% |
Dividends
AUPH vs. VSEC - Dividend Comparison
AUPH has not paid dividends to shareholders, while VSEC's dividend yield for the trailing twelve months is around 0.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
VSEC VSE Corporation | 0.23% | 0.23% | 0.42% | 0.77% | 0.85% | 0.59% | 0.94% | 0.89% | 1.00% | 0.54% | 0.51% | 0.68% |
Financials
AUPH vs. VSEC - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and VSE Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
AUPH vs. VSEC - Profitability Comparison
AUPH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a gross profit of 71.20M and revenue of 77.71M. Therefore, the gross margin over that period was 91.6%.
VSEC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, VSE Corporation reported a gross profit of 0.00 and revenue of 324.58M. Therefore, the gross margin over that period was 0.0%.
AUPH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported an operating income of 41.42M and revenue of 77.71M, resulting in an operating margin of 53.3%.
VSEC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, VSE Corporation reported an operating income of 32.75M and revenue of 324.58M, resulting in an operating margin of 10.1%.
AUPH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Aurinia Pharmaceuticals Inc. reported a net income of 34.36M and revenue of 77.71M, resulting in a net margin of 44.2%.
VSEC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, VSE Corporation reported a net income of 29.06M and revenue of 324.58M, resulting in a net margin of 9.0%.
Frequently Asked Questions
AUPH and VSEC have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VSEC has higher volatility (22.49%) compared to AUPH (10.84%). In terms of maximum drawdown, AUPH dropped -87.58% vs VSEC's -76.09%.
AUPH currently has the higher Sharpe Ratio (2.13 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AUPH and VSEC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer